Base Year Value ()
x.x %
x.x %
CAGR ()
x.x %
x.x %
Forecast Year Value ()
x.x %
x.x %
Historical Data Period
Largest Region
Forecast Period
Mercado de tipificación de grupos sanguíneos por productos (consumibles, instrumentos y reactivos, servicios), por tipo de prueba (pruebas ABO, tipificación de antígenos, detección de anticuerpos, pruebas cruzadas, pruebas HLA), por técnica (pruebas serológicas, pruebas moleculares), por usuario final (laboratorios hospitalarios, laboratorios independientes y bancos de sangre) y región, tendencias globales y pronóstico de 2023 a 2029
Instant access to hundreds of data points and trends
- Market estimates from 2014-2029
- Competitive analysis, industry segmentation, financial benchmarks
- Incorporates SWOT, Porter's Five Forces and risk management frameworks
- PDF report or online database with Word, Excel and PowerPoint export options
- 100% money back guarantee
Descripción general del mercado de tipificación de grupos sanguíneos
Se espera que el mercado de tipificación de grupos sanguíneos crezca a una tasa compuesta anual del 9,8 % entre 2023 y 2029. Se espera que alcance más de 7400 millones de USD en 2029 desde 3000 millones de USD en 2020.
Se espera que el mercado de tipificación de grupos sanguíneos experimente un rápido crecimiento en los próximos años debido al uso cada vez mayor del proceso en las ciencias forenses y las pruebas prenatales, el creciente número de víctimas de accidentes y traumas que requerirán más transfusiones de sangre y la creciente demanda de sangre y sus derivados.
Los factores principales, los avances en el desarrollo de nuevos productos y la introducción de tecnologías interesantes continuaron teniendo un impacto en el mercado de tipificación de grupos sanguíneos.
El objetivo principal de las primeras investigaciones y desarrollos de nuevos productos era continuar con las transfusiones de sangre a pesar de la escasez de sangre en tiempos de guerra. Esta compatibilidad precisa era imposible anteriormente basándose únicamente en antígenos, sin embargo, iMED demostró que las unidades de sangre de donantes inicialmente etiquetadas como A- eran otro fenotipo Rh AB (posterior). El análisis de electroforesis de eritrocitos humanos mostró características de unión adicionales. Nuestra comprensión de todas las facetas de la compatibilidad ABO ha cambiado como resultado de este trabajo. En última instancia, resultó en el manejo de la OPO de tipo donante, que se creó en 1959 y se convirtió en una práctica operativa estándar en 1970, en todos los servicios de transfusión a nivel mundial.
La presión arterial varía de persona a persona en todo el mundo y generalmente se divide en cuatro tipos.
El factor ABO se refiere a los polimorfismos genéticos en los genes que codifican los antígenos A o B que se encuentran en los glóbulos rojos. El grupo sanguíneo de una persona está determinado por sus alelos subyacentes en uno de seis genes, tres de los cuales tienen loci genéticos (A, B o G) y tres de los cuales tienen loci genéticos (IA, IB y II). ABO y Rh(D?) son los tipos de sangre más significativos desde una perspectiva clínica.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (miles de millones de USD), volumen (miles de unidades) |
| Segmentación | Por productos, por tipo de prueba, por técnica, por usuario final, por región |
| Por tipo de prueba de resina |
|
| Por tipo de prueba |
|
| Por técnica |
|
| Por el usuario final |
|
| Por región |
|
La tipificación ABO es posible mediante la fenotipificación indirecta realizada en anticuerpos séricos o mediante una secuencia de ADN nativa como plantilla para la amplificación por PCR utilizando alelos clonados como sondas de hibridación para producir secuencias de ADN localizadas.
Una de las mejores razas para el estudio de la diversidad genómica bovina es el ganado con alto contenido de tritio debido a su alta reacción de autosegmentación, que en la tipificación ABO/E(P) indica seis genotipos. El número de personas que necesitan transfusiones de sangre está aumentando progresivamente en todo el mundo. La ubicación geográfica, la densidad de población y la gravedad de la guerra o los accidentes médicos contribuyen a la escasez de sangre en los bancos de sangre centralizados. Los pacientes con enfermedades hereditarias graves, como la talasemia o la anemia de células falciformes, que requieren transfusiones continuas durante toda su vida, deben recibir transfusiones de donantes compatibles. La tipificación ABO es necesaria para confirmar que los grupos sanguíneos del donante y el receptor son compatibles para asegurar la tasa de éxito.
El tipo más común en el mundo es el O, y si hay escasez, se puede donar a otros O. Un tipo AB puede donar a cualquier grupo, pero solo puede recibir de otros tipos AB. Debido a que carecen de antígenos tipo B, que indican actividad tipo A, las personas tipo A solo pueden recibir de otros AA y no pueden donar; una persona con rasgos de acciones tanto de tipo A1 como de tipo A2 sí puede.
Debido al impacto de la pandemia de COVID-19 en las cuestiones relacionadas con la fabricación y la cadena de suministro, la disminución de las visitas de pacientes y la caída de las donaciones de sangre y las transfusiones, se están utilizando menos de estas herramientas de diagnóstico. Como resultado, la demanda mundial de estos productos se vio obstaculizada. Por ejemplo, el Instituto Francés de Sangre (EFS) informa que durante el pico de la pandemia en septiembre de 2020, las donaciones de sangre en Francia alcanzaron mínimos históricos como resultado de la cancelación de las recolecciones móviles de sangre en lugares de trabajo y universidades, que eran responsables de aproximadamente el 80,0% de las donaciones de sangre en Francia.
La pandemia de 2020 afectó las ventas de tipificación de grupos sanguíneos en todo el mundo. Algunos participantes conocidos del mercado informaron una reducción considerable en los ingresos por ventas anuales. Competidores globales críticos, como Bio Rad Laboratories, Inc., por ejemplo, tuvieron una disminución del 7,69% en sus sectores de diagnóstico clínico, que comprenden sistemas de identificación y microplacas, durante el año fiscal 2020 en comparación con el mismo período en 2019. Sin embargo, la empresa vio un aumento del 16,1% en las ventas de su división de diagnóstico clínico en el año fiscal 2021. Sin embargo, se proyecta que durante el período de pronóstico, el mercado volverá a sus niveles de crecimiento previos a la pandemia gracias al uso vigoroso de la tecnología automatizada y a mejores visitas de pacientes.
[título id="attachment_14596" align="aligncenter" width="1920"]
Frequently Asked Questions
• What is the worth of Blood Group Typing Market?
The Blood Group Typing Market size had crossed USD 3 Billion in 2020 and will observe a CAGR of more than 9.8% up to 2029.
• What are some of the market's driving forces?
Factors like the increasing number of road accidents, need for blood grouping to decide prenatal testing, rise in blood donations, trauma cases with a requirement for blood transfusion, and inclusion of forensic sciences would inspire better growth for the blood group typing market.
• Which are the top companies to hold the market share in Blood Group Typing Market?
Danaher Corporation, Immucor Inc., Bio-Rad Laboratories Inc., BAG Health Care GmbH, Quotient Limited, Grifols S.A., DAY medical SA, Novacyt Group, Ortho Clinical Diagnostics Inc., Merck KGaA, Rapid Labs, CareDx Inc., AXO Science, DIAGAST and Agena Bioscience Inc. are the major blood group typing market players.
• Which is the largest regional market for Blood Group Typing Market?
The region's largest share is in North America. Products manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
Blood Group Typing Market Segment Analysis
The Blood Group Typing Market is segmented based on Products, Test Type, Technique, End User, and Region, Global trends and forecast.
On the basis of Products, the market is segmented into Consumable, Instruments & Reagents, Services.
Consumable, Instruments and reagents & services are three product categories that can be used to segment the global market. Due to the widespread usage of these items in various processes, the Instruments and Reagents sector dominated the market. One of the main causes of segmental enlargement is the rising amount of blood donors and transfusions. During the projection period, the Services segment is expected to experience positive growth possibilities. Technology developments, strategic initiatives, and an increase in the use of sophisticated instruments for these operations are expected to boost industry growth.
On the basis of Test Type, the market is segmented into ABO Testing, Antigen Testing, Antibody Screening, Cross-Matching, HLA Testing.
Due to an increase in blood transfusions, a rise in the prevalence of chronic diseases, and prenatal testing, the antibody screening segment dominated the market. Patients who are pregnant need to undergo a number of screening procedures, such as blood group and antibody screening. Prenatal testing is becoming more common, which is accelerating the segment's growth.
In 2021, the ABO testing market category occupied the second-place spot. Segmental expansion is being boosted by the growing use of ABO blood typing to detect and match organ and tissue transplant procedures. Due to the increasing use of these tests for patients needing long-term transfusion therapy, such as those with sickle cell disease, to get phenotypically suitable units, the antigen typing category is predicted to hold the third-largest market share.
As they are used for the identification and matching of organ and tissue transplantation procedures in the region, cross-matching tests and HLA typing are also expected to expand with a sizable CAGR.
On the basis of Technique, the market is segmented into Serology Tests, Molecular Tests.
Serology testing and molecular tests are two market segments based on technology. Due to increasing efforts to encourage voluntary blood donations and new product introductions, the serology tests category held a disproportionately large percentage of the global blood group typing market. One of the more established techniques in this sector is serology testing, which can be applied in a lab setting or during a research project. Additionally, they are accessible and simple to use, which fuels the market's desire for these goods. Because molecular testing is becoming more and more popular, the market for them is expected to expand dramatically. The main driver of the segment's growth is the strong sensitivity of molecular tests to detection.
On the basis of End User, the market is segmented into Hospital Based Laboratories, Independent Laboratories & Blood Banks.
Due to an increase in independent laboratories and blood banks, notably in emerging nations, this market segment, which now holds a monopoly, is anticipated to expand. There were around 110,000 medical laboratories in India, according to a news report from the New Indian Express from March 2020. During the projection period, it is anticipated that the existence of laboratories in important countries will fuel the segment's expansion.
Hospital-based laboratories make up the second-largest market share in terms of end users. During the projection period, segmental expansion will be aided by advantageous reimbursement policies and the growing number of hospitals in developed nations. as well as independent labs & blood banks. Due to an increase in independent laboratories and blood banks, notably in emerging nations, this market segment, which now holds a monopoly, is anticipated to expand. There were around 110,000 medical laboratories in India, according to a news report from the New Indian Express from March 2020. During the projection period, it is anticipated that the existence of laboratories in important countries will fuel the segment's expansion.
[caption id="attachment_14600" align="aligncenter" width="1920"]
Blood Group Typing Market Players
Danaher Corporation, Immucor Inc., Bio-Rad Laboratories Inc., BAG Health Care GmbH, Quotient Limited, Grifols S.A., DAY medical SA, Novacyt Group, Ortho Clinical Diagnostics Inc., Merck KGaA, Rapid Labs, CareDx Inc., AXO Science, DIAGAST and Agena Bioscience Inc. are the major blood group typing market players.
10 November, 2022: Danaher Corporation announced its entrance in a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacon is a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.
25 August, 2022: Bio-Rad Laboratories, Inc. introduced a range of type 1 antibodies that inhibit the binding of evolocumab to its target, human proprotein convertase subtilisin/kexin type 9, a protein that has been shown to play a key role in the regulation of cholesterol levels.
Who Should Buy? Or Key Stakeholders
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
- Investors
- Regulatory Authorities
Blood Group Typing Market Regional Analysis
The Blood Group Typing Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
The primary drivers of the expansion of the market under study are an increase in traffic accidents and the prevalence of chronic disorders. The United States will rank among the top countries for road traffic in July 2022, according to the Association for Safe International Road Travel, with almost 284 million vehicles on the road as of the third quarter of 2021. Additionally, it was stated that as of 2020, more than 228.7 million drivers have valid licences. The amount of traffic is one of the factors contributing to an increase in traffic accidents. Over half of the 12.15 million vehicles involved in crashes in the United States in September 2020 were passenger cars. The need for blood group typing is rising as a result of the rising number of traffic fatalities and collisions. Over the course of the forecast period, this is anticipated to increase demand for the blood group typing market.
Additionally, the need for blood transfusions is growing in the United States. According to American National Red Cross estimates, roughly 36,000 units of red blood cells are required each day, and nearly 25 million blood components are transfused in the United States annually as of October 2021. There is a great demand for blood typing in each of the aforementioned situations, and as more of these situations arise, the market will grow.
Asia-Pacific (APAC) would see the fastest market growth in the future years as a result of the rise in chronic diseases, many of which require blood type identification for efficient treatment. The market for regional blood group typing is growing quickly for several reasons, including the increasing incidence of infectious diseases and the rise in the number of trauma and accident patients who need immediate blood transfusions, for which knowing the blood type is crucial.
[caption id="attachment_14601" align="aligncenter" width="1920"]
Key Market Segments: Blood Group Typing Market
Blood Group Typing Market By Products, 2020-2029, (USD Billion, Thousand Units)- Consumable
- Instruments & Reagents
- Services
- Abo Tests
- Antigen Typing
- Antibody Screening
- Cross-Matching
- Hla Testing
- Serology Tests
- Molecular Tests
- Hospital-Based Laboratories
- Independent Laboratories & Blood Banks
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the blood group typing market over the next 7 years?
- Who are the major players in the blood group typing market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the blood group typing market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the blood group typing market?
- What is the current and forecasted size and growth rate of the global blood group typing market?
- What are the key drivers of growth in the blood group typing market?
- What are the distribution channels and supply chain dynamics in the blood group typing market?
- What are the technological advancements and innovations in the blood group typing market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the blood group typing market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the blood group typing market?
- What are the service offerings and specifications of leading players in the market?
- What is the pricing trend of blood group typing in the market and what is the impact of raw material prices on the price trend?
- Introducción
- Definición de mercado
- Segmentación del mercado
- Cronología de la investigación
- Supuestos y limitaciones
- Metodología de la investigación
- Minería de datos
- Investigación secundaria
- Investigación primaria
- Asesoramiento de expertos en la materia
- Controles de calidad
- Revisión final
- Triangulación de datos
- Enfoque de abajo hacia arriba
- Enfoque de arriba hacia abajo
- Flujo de investigación
- Fuentes de datos
- Minería de datos
- Resumen ejecutivo
- Descripción general del mercado
- Perspectivas del mercado mundial de tipificación de grupos sanguíneos
- Factores impulsores del mercado
- Restricciones del mercado
- Oportunidades de mercado
- Impacto de Covid-19 en el mercado de tipificación de grupos sanguíneos
- Modelo de las cinco fuerzas de Porter
- Amenaza de nuevos participantes
- Amenaza de sustitutos
- Poder de negociación de los proveedores
- Poder de negociación de los clientes
- Grado de competencia
- Análisis de la cadena de valor de la industria
- Perspectivas del mercado mundial de tipificación de grupos sanguíneos
- Mercado mundial de tipificación de grupos sanguíneos por PRODUCTO (miles de millones de USD, miles de unidades), 2020-2029
- Consumibles
- Instrumentos y reactivos
- Servicios
- Mercado mundial de tipificación de grupos sanguíneos por tipo de prueba (miles de millones de USD, miles de unidades), 2020-2029
- Pruebas ABO
- Tipificación de antígenos
- Detección de anticuerpos
- Prueba de compatibilidad cruzada
- Prueba de HLA
- Mercado mundial de tipificación de grupos sanguíneos por técnica (miles de millones de USD, miles de unidades), 2020-2029
- Pruebas serológicas
- Pruebas moleculares
- Mercado mundial de tipificación de grupos sanguíneos por usuario final (miles de millones de USD, miles de unidades), 2020-2029
- Laboratorios en hospitales
- Laboratorios independientes y bancos de sangre
- Mercado mundial de tipificación de grupos sanguíneos por región (miles de millones de USD, miles de unidades), 2020-2029
- América del norte
- A NOSOTROS
- Canadá
- México
- Sudamerica
- Brasil
- Argentina
- Colombia
- Resto de Sudamérica
- Europa
- Alemania
- Reino Unido
- Francia
- Italia
- España
- Rusia
- Resto de Europa
- Asia Pacífico
- India
- Porcelana
- Japón
- Corea del Sur
- Australia
- Sudeste asiático
- Resto de Asia Pacífico
- Oriente Medio y África
- Emiratos Árabes Unidos
- Arabia Saudita
- Sudáfrica
- Resto de Oriente Medio y África
- América del norte
- Perfiles de empresas*
(Descripción general de la empresa, descripción general de la empresa, PRODUCTO ofrecido, desarrollos recientes)
- Corporación Danaher
- Inmucor Inc.
- Laboratorios Bio-Rad Inc.
- BAG Salud y Cuidados Intensivos
- Cociente limitado
- Grifols SA
- DIA medico SA
- Grupo Novacyt
- Diagnóstico Clínico Ortopedia Inc.
- Merck KGaA
- Laboratorios rápidos
- Cuidado de la salud en general.
- Ciencia AXO
- Diagnóstico
- Agena Bioscience Inc.
*La lista de empresas es orientativa
LISTA DE TABLAS
TABLE 1 GLOBAL BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 2 GLOBAL BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 3 GLOBAL BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 4 GLOBAL BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 5 GLOBAL BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 6 GLOBAL BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 7 GLOBAL BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 8 GLOBAL BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 9 GLOBAL BLOOD GROUP TYPING MARKET BY REGION (USD BILLION) 2020-2029
TABLE 10 GLOBAL BLOOD GROUP TYPING MARKET BY REGION (THOUSAND UNITS) 2020-2029
TABLE 11 NORTH AMERICA BLOOD GROUP TYPING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 12 NORTH AMERICA BLOOD GROUP TYPING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 13 NORTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 14 NORTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 15 NORTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 16 NORTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 17 NORTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 18 NORTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 19 NORTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 20 NORTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 21 US BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 22 US BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 23 US BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 24 US BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 25 US BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 26 US BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 27 US BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 28 US BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 29 CANADA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 30 CANADA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 31 CANADA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 32 CANADA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 33 CANADA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 34 CANADA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 35 CANADA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 36 CANADA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 37 MEXICO BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 38 MEXICO BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 39 MEXICO BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 40 MEXICO BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 41 MEXICO BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 42 MEXICO BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 43 MEXICO BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 44 MEXICO BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 45 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 46 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 47 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 48 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 49 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 50 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 51 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 52 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 53 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 54 SOUTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 55 BRAZIL BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 56 BRAZIL BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 57 BRAZIL BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 58 BRAZIL BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 59 BRAZIL BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 60 BRAZIL BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 61 BRAZIL BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 62 BRAZIL BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 63 ARGENTINA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 64 ARGENTINA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 65 ARGENTINA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 66 ARGENTINA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 67 ARGENTINA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 68 ARGENTINA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 69 ARGENTINA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 70 ARGENTINA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 71 COLOMBIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 72 COLOMBIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 73 COLOMBIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 74 COLOMBIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 75 COLOMBIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 76 COLOMBIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 77 COLOMBIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 78 COLOMBIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 79 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 80 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 81 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 82 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 83 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 84 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 85 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 86 REST OF SOUTH AMERICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 87 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 88 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 89 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 90 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 91 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 92 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 93 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 94 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 95 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 96 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 97 INDIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 98 INDIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 99 INDIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 100 INDIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 101 INDIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 102 INDIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 103 INDIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 104 INDIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 105 CHINA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 106 CHINA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 107 CHINA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 108 CHINA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 109 CHINA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 110 CHINA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 111 CHINA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 112 CHINA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 113 JAPAN BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 114 JAPAN BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 115 JAPAN BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 116 JAPAN BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 117 JAPAN BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 118 JAPAN BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 119 JAPAN BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 120 JAPAN BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 121 SOUTH KOREA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 122 SOUTH KOREA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 123 SOUTH KOREA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 124 SOUTH KOREA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 125 SOUTH KOREA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 126 SOUTH KOREA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 127 SOUTH KOREA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 128 SOUTH KOREA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 129 AUSTRALIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 130 AUSTRALIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 131 AUSTRALIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 132 AUSTRALIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 133 AUSTRALIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 134 AUSTRALIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 135 AUSTRALIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 136 AUSTRALIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 137 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 138 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 139 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 140 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 141 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 142 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 143 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 144 SOUTH-EAST ASIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 145 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 146 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 147 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 148 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 149 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 150 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 151 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 152 REST OF ASIA PACIFIC BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 153 EUROPE BLOOD GROUP TYPING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 154 EUROPE BLOOD GROUP TYPING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 155 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 156 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 157 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 158 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 159 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 160 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 161 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 162 ASIA-PACIFIC BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 163 GERMANY BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 164 GERMANY BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 165 GERMANY BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 166 GERMANY BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 167 GERMANY BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 168 GERMANY BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 169 GERMANY BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 170 GERMANY BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 171 UK BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 172 UK BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 173 UK BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 174 UK BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 175 UK BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 176 UK BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 177 UK BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 178 UK BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 179 FRANCE BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 180 FRANCE BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 181 FRANCE BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 182 FRANCE BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 183 FRANCE BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 184 FRANCE BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 185 FRANCE BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 186 FRANCE BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 187 ITALY BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 188 ITALY BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 189 ITALY BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 190 ITALY BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 191 ITALY BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 192 ITALY BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 193 ITALY BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 194 ITALY BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 195 SPAIN BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 196 SPAIN BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 197 SPAIN BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 198 SPAIN BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 199 SPAIN BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 200 SPAIN BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 201 SPAIN BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 202 SPAIN BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 203 RUSSIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 204 RUSSIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 205 RUSSIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 206 RUSSIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 207 RUSSIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 208 RUSSIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 209 RUSSIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 210 RUSSIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 211 REST OF EUROPE BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 212 REST OF EUROPE BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 213 REST OF EUROPE BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 214 REST OF EUROPE BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 215 REST OF EUROPE BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 216 REST OF EUROPE BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 217 REST OF EUROPE BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 218 REST OF EUROPE BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 219 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 220 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 221 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 222 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 223 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 224 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 225 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 226 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 227 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 228 MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 229 UAE BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 230 UAE BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 231 UAE BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 232 UAE BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 233 UAE BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 234 UAE BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 235 UAE BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 236 UAE BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 237 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 238 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 239 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 240 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 241 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 242 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 243 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 244 SAUDI ARABIA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 245 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 246 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 247 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 248 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 249 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 250 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 251 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 252 SOUTH AFRICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
TABLE 253 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 254 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 255 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (USD BILLION) 2020-2029
TABLE 256 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TEST TYPE (THOUSAND UNITS) 2020-2029
TABLE 257 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (USD BILLION) 2020-2029
TABLE 258 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY TECHNIQUE (THOUSAND UNITS) 2020-2029
TABLE 259 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY END USER (USD BILLION) 2020-2029
TABLE 260 REST OF MIDDLE EAST AND AFRICA BLOOD GROUP TYPING MARKET BY END USER (THOUSAND UNITS) 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 RESEARCH FLOW
FIGURE 5 GLOBAL MILITARY AEROSPACE COATINGS BY PRODUCT, USD BILLION, 2020-2029
FIGURE 6 GLOBAL MILITARY AEROSPACE COATINGS BY TEST TYPE, USD BILLION, 2020-2029
FIGURE 7 GLOBAL MILITARY AEROSPACE COATINGS BY TECHNIQUE, USD BILLION, 2020-2029
FIGURE 8 GLOBAL MILITARY AEROSPACE COATINGS BY END USER, USD BILLION, 2020-2029
FIGURE 9 GLOBAL MILITARY AEROSPACE COATINGS BY REGION, USD BILLION, 2020-2029
FIGURE 10 PORTER’S FIVE FORCES MODEL
FIGURE 11 GLOBAL MILITARY AEROSPACE COATINGS BY PRODUCT, USD BILLION, 2021
FIGURE 12 GLOBAL MILITARY AEROSPACE COATINGS BY TEST TYPE, USD BILLION, 2021
FIGURE 13 GLOBAL MILITARY AEROSPACE COATINGS BY TECHNIQUE, USD BILLION, 2021
FIGURE 14 GLOBAL MILITARY AEROSPACE COATINGS BY END USER, USD BILLION, 2021
FIGURE 15 GLOBAL MILITARY AEROSPACE COATINGS BY REGION, USD BILLION, 2021
FIGURE 16 MARKET SHARE ANALYSIS
FIGURE 17 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 18 IMMUCOR INC.: COMPANY SNAPSHOT
FIGURE 19 BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
FIGURE 20 BAG HEALTH CARE GMBH: COMPANY SNAPSHOT
FIGURE 21 QUOTIENT LIMITED: COMPANY SNAPSHOT
FIGURE 22 GRIFOLS S.A.: COMPANY SNAPSHOT
FIGURE 23 DAY MEDICAL SA: COMPANY SNAPSHOT
FIGURE 24 NOVACYT GROUP: COMPANY SNAPSHOT
FIGURE 25 ORTHO CLINICAL DIAGNOSTICS INC.: COMPANY SNAPSHOT
FIGURE 26 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 27 RAPID LABS: COMPANY SNAPSHOT
FIGURE 28 CAREDX INC.: COMPANY SNAPSHOT
FIGURE 29 AXO SCIENCE: COMPANY SNAPSHOT
FIGURE 30 DIAGAST: COMPANY SNAPSHOT
FIGURE 31 AGENA BIOSCIENCE INC.: COMPANY SNAPSHOT
DOWNLOAD FREE SAMPLE REPORT
License Type
SPEAK WITH OUR ANALYST
Want to know more about the report or any specific requirement?
WANT TO CUSTOMIZE THE REPORT?
Our Clients Speak
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Yosuke Mitsui
Senior Associate Construction Equipment Sales & Marketing
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
